Literature DB >> 30757979

CBT for schizophrenia: a critical viewpoint.

S Jauhar1, K R Laws2, P J McKenna3.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30757979     DOI: 10.1017/S0033291718004166

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


× No keyword cloud information.
  4 in total

1.  Are Randomized Controlled Trials on Pharmacotherapy and Psychotherapy for Positive Symptoms of Schizophrenia Comparable? A Systematic Review of Patient and Study Characteristics.

Authors:  Irene Bighelli; Claudia Leucht; Maximilian Huhn; Cornelia Reitmeir; Felicitas Schwermann; Sofia Wallis; John M Davis; Stefan Leucht
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

2.  Do adjunctive art therapies reduce symptomatology in schizophrenia? A meta-analysis.

Authors:  Keith R Laws; William Conway
Journal:  World J Psychiatry       Date:  2019-12-19

3.  The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta-analytic evaluation of recent meta-analyses.

Authors:  Falk Leichsenring; Christiane Steinert; Sven Rabung; John P A Ioannidis
Journal:  World Psychiatry       Date:  2022-02       Impact factor: 49.548

4.  Improving treatments for psychotic disorders: beyond cognitive behaviour therapy for psychosis.

Authors:  B Nelson; L Torregrossa; A Thompson; L A Sass; S Park; J A Hartmann; P D McGorry; M Alvarez-Jimenez
Journal:  Psychosis       Date:  2020-06-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.